Home › Trial NCT02885974
Celecoxib With Chemotherapy in Localized, Muscle-Invasive Bladder Cancer
- Trial IDNCT02885974
- StatusCompleted
- PhasePhase 1
- Study typeInterventional
- SponsorBaylor College of Medicine
- Enrollment22
- Start date2016-12
- ConditionsBladder Cancer
Enriched analysis
Parsed endpoints, structured eligibility, drug class and a plain-English summary — shown to verified visitors to prevent automated scraping.
Human verification coming soon — the enriched analysis will be viewable here.
Trial data from ClinicalTrials.gov (U.S. public domain) and ISRCTN (CC BY 4.0), used with attribution. TrialLens is an independent index, not affiliated with or endorsed by ClinicalTrials.gov, the NIH, or any trial sponsor. For research only — not medical advice.